Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-06-18

FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (PAI Holdings, LLC dba PAI Pharma)

View source ↗

Summary

FDA approves the original application for cetirizine hydrochloride as a generic drug to be marketed by PAI Holdings, dba PAI Pharma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cetirizine hydrochloride (Cetirizine hydrochloride)

Snippet

ORIG AP for CETIRIZINE HYDROCHLORIDE (CETIRIZINE HYDROCHLORIDE)